)
Edge11 Sep 2026
Texas Pacific Land Corporation: Keeper of the Permian Basin
Land once granted to a failed 19th-century railroad now generates royalties for Texas Pacific Land Corporation across the Permian Basin.
Cadrenal Therapeutics
Cadrenal Therapeutics (CVKD) investor relations material
Cadrenal Therapeutics AGM 2026 summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.AGM 2026 summary24 Sep, 2026
Opening remarks and agenda
Meeting called to order by the CEO, with board members, management, legal counsel, and auditors present virtually.
The agenda included five business items, with voting instructions and Q&A procedures explained.
Board and executive committee updates
The board is divided into three classes, with the Class I director's term expiring at this meeting.
Quang X. Pham was nominated for re-election as Class I director for a three-year term.
Shareholder proposals
Election of one director for a three-year term.
Ratification of the independent registered public accounting firm for 2026.
Approval of an amendment to the 2022 Successor Equity Incentive Plan to increase available shares.
Approval of issuance of up to 960,000 shares upon exercise of Series C-1 warrants.
Approval of potential adjournment to solicit further votes if needed.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Cadrenal Therapeutics
- Late-stage pipeline with orphan designations targets $3B+ cardiac and rare disease markets.CVKD
Investor presentation - Net loss improved and clinical advances made, but more funding is needed for future trials.CVKDQ2 2026
- Annual meeting seeks approval for director, auditor, equity plan, and new share issuance.CVKDProxy filing
- Stockholders will vote on director election, auditor ratification, equity plan, and warrant issuance.CVKDProxy filing
- Stockholders will vote on director election, auditor ratification, equity plan, and warrant issuance.CVKDProxy filing
- Registering 2.94M shares for resale from PIPE warrants, with high dilution and capital risk.CVKDRegistration filing
- CAD-1005 offers a novel, upstream approach to HIT, aiming to improve outcomes and reduce costs.CVKDLytham Partners Spring 2026 Investor Conference
- First-in-class 12-LOX inhibitor CAD-1005 targets HIT, aiming for $1B+ market with Phase 3 in 2027.CVKDInvestor presentation
- Net loss narrowed and cash runway extended by $2.5M financing, enabling Phase 3 trial advancement.CVKDQ1 2026
Next Cadrenal Therapeutics earnings date
Lytham Partners Fall 2026 Investor Conference29 Sep, 2026
Cadrenal Therapeutics
Next Cadrenal Therapeutics earnings date
Lytham Partners Fall 2026 Investor Conference29 Sep, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage